Interim report January-March 2016: Good development in key areas
· First phase in United Arab Emirates ongoing and proceeding according to plan · Improving results for GHP Vårdsamverkan (GHP Collaborative Care), our new collaboration with the insurance companies · Continuing good organic growth · Urologcentrum acquired and taken over First quarter 2016 · Sales revenues increased to SEK 231.5 million (217.6) and organic growth amounted to 5 percent (5) · EBITDA amounted to SEK 18.1 million (19.9) · EBITDA margin amounted to 7.8 percent (9.1) · Result after tax (EAT) amounted to SEK 9.4 million (10.3) · Result per share